Lab Manager | Run Your Lab Like a Business

Phenomenex Introduces Aeris™ Core-Shell HPLC/UHPLC Technology for Proteins and Peptides

Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Aeris™ – core-shell HPLC/UHPLC columns specially designed for the analysis of proteins and peptides.

by Other Author

Torrance, CA (November 1, 2011) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Aeris™ – core-shell HPLC/UHPLC columns specially designed for the analysis of proteins and peptides. These new high-performance columns deliver higher resolution and peak capacities than other bioseparation media, producing sub-2 micron results on any LC instrument. With virtually no bleed, Aeris columns are highly compatible with MS.

Aeris columns are offered in wide- and small-pore configurations. Aeris WIDEPORE 3.6-micron core-shell columns are optimized for the separation of intact proteins and polypeptides, and are available in three selectivities – XB-C18, XB-C8 and C4. Because the 3.6-micron core-shell particles produce lower backpressures than traditional media, longer or coupled columns can be used to increase resolving power on both HPLC and UHPLC instruments.

Aeris PEPTIDE 3.6-micron and 1.7-micron columns, designed with a small pore size, are recommended for the separation of low molecular weight peptides and for peptide mapping. The novel XB-C18 stationary phase provides the ideal surface chemistry for resolving peptides. Aeris PEPTIDE 3.6-micron particles offer ultra-high performance at backpressures compatible with both HPLC and UHPLC instruments. On UHPLC systems, the 1.7-micron Aeris particles can deliver higher peak capacities than fully porous sub-2 micron columns.

“The new Aeris columns are ‘plug and play,’ requiring very little work in method transfer,” comments Kari Kelly, brand manager for Phenomenex. “With a little method optimization, users can achieve even higher resolution and better performance, and our PhenoLogix support team is ready to help customers with their switch to Aeris.”

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. For more information on Phenomenex, visit www.phenomenex.com.